Tukysa 150 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F47QE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,763
Award facts
- Contract value 100% obligated
- $26,762.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,762.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of TUKYSA 150 mg tablets (120-count units). This is a non-set-aside competitive award with performance completion targeted for February 12, 2026, and fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract executed under AmerisourceBergen's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This primary IDC vehicle enables comprehensive pharmaceutical supply across multiple therapeutic domains to support military healthcare systems globally.
TUKYSA (tucatinib) is a targeted cancer therapy used in oncology treatment protocols, consistent with AmerisourceBergen's role as a critical federal pharmaceutical distributor. The contractor's extensive portfolio with the Defense Logistics Agency demonstrates established capability in meeting federal procurement requirements for brand-name and generic medications, vaccines, and specialized medical supplies serving the Defense Health Agency and other government healthcare systems. This award reflects ongoing reliance on the contractor's supply chain infrastructure to support military medical readiness and related federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F47QE?
SPE2DR26F47QE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F47QE worth?
The government has obligated $26,763 on SPE2DR26F47QE.
Is contract SPE2DR26F47QE an order under another contract?
Yes. SPE2DR26F47QE is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47QE competed?
The extent of competition for SPE2DR26F47QE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award